Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects

International Journal of Obesity

Volumn 21, Issue 12, 1997, Pages 1111-1114

  Del Rio, G ^c   Procopio, M ^c   Bondi, M ^c   Marrama, P ^c   Menozzi, R ^c   Oleandri, S E ^c   Grottoli, S ^c   Maccario, M ^c   Velardo, A ^c   Ghigo, E ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c NONE

Author keywords

Acetylcholine; Catecholamines; Glucose; Insulin; Obesity; Pyridostigmine

Indexed keywords

ACETYLCHOLINE; ALUMINUM OXIDE; CHOLINESTERASE INHIBITOR; GLUCOSE; GLUCOSE OXIDASE; INSULIN; NORADRENALIN; PYRIDOSTIGMINE;

ADULT; ARTICLE; BODY MASS; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCHEMICAL DETECTION; EXTRACTION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; NORADRENALIN BLOOD LEVEL; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TIME;

ANIMALIA;

EID: 0142203983     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800523     Document Type: Article

References (25)

1. Bergman RN, Miller RE. Direct enhancement of insulin secretion by vagal stimulation of the isolated pancreas. Am J Physiol 1973; 225: 481-486.
2. Bloom SR, Edwards AV. Pancreatic endocrine responses to stimulation of peripheral ends of the vagus nerves in conscious calves. J Physiol 1981; 315: 31-41.
3. Ahren B, Taborsky Jr GJ. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology 1986; 118: 1551-1557.
4. Iversen J. Effect of acetylcholine on the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Diabetes 1973; 22: 381-387.
5. Kaneto A., Kajinuma H, Kosaka K, Nakao K. Stimulation of insulin secretion by parasympathomimetic agents. Endocrinology 1968; 83: 651-658.
6. Strubbe JH. Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in tha rat. Am J Physiol 1989; 263: R615-R618.
7. Larrimer JN, Mazzaferri EL, Cataland S, Mekhjian HS. Effect of atropine on glucose-stimulated gastric inhibitory poly-peptide. Diabetes 1978; 27: 638-642.
8. Jeanrenaud B, Halimi S, Van de Werve G. Neuro-endocrine disorders seen as triggers of the triad: obesity-insulin resistance-abnormal glucose tolerance. Diab Metab Rev 1985; 1: 261-291.
9. Lee HC, Curry DL, Stern JS. Direct effect of CNS on insulin secretion in obese zucker rats: involvement of vagus nerve. Am J Physiol 1989; 256: E439-444.
10. Rohner-Jeanrenaud F, Jeanrenaud B. Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinology 1985; 116: 830-834.
11. Tappy L, Chiolero R, Randin JP, Burckhardt P, Felber JP. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese humans subjects. Horm Metab Res 1986; 18: 821-826.
12. Schneeberger D, Tappy L, Temler E, Jequier E. Effects of muscarinic blockade on insulin secretion and on glucose-induced thermogenesis in lean and obese human subjects. Eur J Clin Invest 1991; 21: 608-615.
13. El-Sabbagh HN, Bloom SR, Adrian TE, Prinz RA, Baron JH, Welboum RB. The effect of pirenzepine on meal-stimulated gastrointestinal hormones. Scand J Gastroenterol 1980; 15: 57-61.
14. Coiro V, Chiodera P, Volpi R, D'Amato L, Camellini L, Rossi G, Pignatti D, Butturini U. Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man. J Endocrinol Invest 1986; 9: 27-30.
15. Page MD, Bevan JS, Dieguez C, Peters JR, Scanlon MF. Cholinergic blockade with pirenzepine improves carbohydrate tolerance and abolishes the GH response to meals in normal subjects. Clin Endocrinol 1989; 30: 519-524.
16. Bevan JS, Ara J, Page MD, Scanlon MF, Peters JR. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics. Clin Endocrinol 1991; 35: 85-91.
17. Premawardhana LDKE, Ismail IS, Riad-Fahmy D, Miell JP, Peters JR, Scanlon MF. Acute cholinergic blockade with low dose of pirenzepine reduces the insulin and the glucose responses to a mixed meal in obese women with the polycystic ovary syndrome. Clin Endocrinol 1994; 40: 617-621.
18. Maccario M, Grottoli S, Procopio M, Oleandri SE, Boffano GM, Savio P, Camanni F, Ghigo E. Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity. J Endocrinol Invest 1997; 20: 8-12
19. Kreisberg RA, Boshell BR, DiPlacido J, Roddam RF. Insulin secretion in obesity. N Engl J Med 1967; 276: 314-319.
20. Polonsky KS, Given BD, Van Cauter E. 24-hours profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988; 82: 442-445.
21. Karam JH, Grodsky GM, Forsham PH. Excessive insulin response to glucose in obese subjects measured by immunochemical assay. Diabetes 1963; 12: 197-201.
22. Astrup A, Christensen NJ, Bulow J, Quaade F. Facultative carbohydrate-induced thermogenesis and its deficiency in human obesity. In: Juel Christensen N, Henriksen O, Lassen NA, (eds). The sympathoadrenal system, Alfred Benzon Symposium. Munksgaard: Copenhagen, 1986, 23: 326-331.
23. Chen N-C, Romsos DR. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 1995; 136: 505-511.
24. Mc Cullough AJ, Miller LJ, Service FJ, VLW Go. Effect of graded intraduodenal glucose infusions on the release and physiological actions of gastric inhibitory polipeptide. J Clin Endocrinol Metab 1983; 56: 234-241.
25. Cooke AR, Clark ED. Effect of first part of duodenum on gastric emptying in dogs: response to acid, fat, glucose, and neural blockade. Gastroenterology 1976; 70: 550-554.